Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover)

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 200 participants.

Also called NCT07827287

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07827287
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Enrolling by invitation (from the registry)

Technical summary

Registry record NCT07827287. Randomized; no masking; primary purpose treatment. Start 2026-02-02 (actual); primary completion 2028-05-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover)
Acronym
Eight-CLOVER
Condition
Atrial Septal Defect
Condition
Vascular Closure Device
Intervention (Device)
Perclose ProStyle™ Suture-Mediated Closure System
Intervention (Other)
Conventional Hemostasis (Manual Compression or Figure-of-Eight Suture)
Lead sponsor
Ewha Womans University Mokdong Hospital (class: other)
Collaborator
Ewha Womans University Seoul Hospital (class: other)

Record details

Record id
cardio:ct-nct07827287
Content hash
a7bdb31a16b4a3af94e06af2d8b4d0e6e2575d1865440bc36ab34c023bbcaf2b